Literature DB >> 31541181

The Shh/Gli signaling cascade regulates myofibroblastic activation of lung-resident mesenchymal stem cells via the modulation of Wnt10a expression during pulmonary fibrogenesis.

Honghui Cao1,2, Xiang Chen1,2, Jiwei Hou1,2, Cong Wang3, Zou Xiang4, Yi Shen5, Xiaodong Han6,7.   

Abstract

Lung-resident mesenchymal stem cells (LR-MSCs) are important regulators of lung repair and regeneration, and evidence suggests that this cell population also plays a vital role in fibrosis. Crosstalk between sonic hedgehog (Shh) signaling and wingless/integrated (Wnt) has been demonstrated in idiopathic pulmonary fibrosis (IPF). However, the underlying correlation between LR-MSCs and the Shh-Wnt signaling cascade remains poorly understood. Here, we identified Wnt10a as a key factor in pulmonary fibrosis. Using a bleomycin mouse model, we found that highly expressed Wnt10a was secreted by LR-MSCs undergoing myofibroblastic differentiation. LR-MSCs with myofibroblast characteristics isolated from fibrotic lungs exhibited increased Shh pathway activity, suggesting their role as Shh targets. In vitro, LR-MSCs responded to stimulation by recombinant Shh, acquiring a myofibroblast phenotype. We further demonstrated that the Shh/glioblastoma (Gli) system machinery regulated LR-MSC-to-myofibroblast transition and pulmonary fibrosis via manipulation of Wnt/β-catenin signaling. Accordingly, inhibition of the Shh-Wnt signaling cascade prevented LR-MSC transformation into myofibroblasts and ameliorated pulmonary fibrotic lesions. Moreover, induction of Wnt10a expression and activation of Shh/Gli signaling were confirmed in human pulmonary fibrosis. In summary, this study linking the Shh-Wnt signaling cascade with LR-MSC fibrogenic activity furthered the current understanding of pulmonary fibrosis pathogenesis and might provide a new perspective in the development of treatment strategies for IPF.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31541181     DOI: 10.1038/s41374-019-0316-8

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  47 in total

Review 1.  Mechanisms of pulmonary fibrosis.

Authors:  Victor J Thannickal; Galen B Toews; Eric S White; Joseph P Lynch; Fernando J Martinez
Journal:  Annu Rev Med       Date:  2004       Impact factor: 13.739

2.  Mesenchymal stem cells reside in virtually all post-natal organs and tissues.

Authors:  Lindolfo da Silva Meirelles; Pedro Cesar Chagastelles; Nance Beyer Nardi
Journal:  J Cell Sci       Date:  2006-05-09       Impact factor: 5.285

3.  Incidence and prevalence of idiopathic pulmonary fibrosis.

Authors:  Ganesh Raghu; Derek Weycker; John Edelsberg; Williamson Z Bradford; Gerry Oster
Journal:  Am J Respir Crit Care Med       Date:  2006-06-29       Impact factor: 21.405

4.  Isolation and characterization of lung resident mesenchymal stem cells capable of differentiating into alveolar epithelial type II cells.

Authors:  Xuemin Gong; Zhaorui Sun; Di Cui; Xiaomeng Xu; Huiming Zhu; Lihui Wang; Weiping Qian; Xiaodong Han
Journal:  Cell Biol Int       Date:  2014-02-10       Impact factor: 3.612

5.  Mucus rheology. Relevance to mucociliary clearance.

Authors:  M Litt
Journal:  Arch Intern Med       Date:  1970-09

6.  The pathology of bleomycin-induced fibrosis is associated with loss of resident lung mesenchymal stem cells that regulate effector T-cell proliferation.

Authors:  Du Jun; Chrystelle Garat; James West; Nathalie Thorn; Kelsey Chow; Timothy Cleaver; Timothy Sullivan; Enrique C Torchia; Christine Childs; Theodore Shade; Mehrdad Tadjali; Abigail Lara; Eva Nozik-Grayck; Stephen Malkoski; Brian Sorrentino; Barbara Meyrick; Dwight Klemm; Mauricio Rojas; David H Wagner; Susan M Majka
Journal:  Stem Cells       Date:  2011-04       Impact factor: 6.277

7.  Multilineage potential of adult human mesenchymal stem cells.

Authors:  M F Pittenger; A M Mackay; S C Beck; R K Jaiswal; R Douglas; J D Mosca; M A Moorman; D W Simonetti; S Craig; D R Marshak
Journal:  Science       Date:  1999-04-02       Impact factor: 47.728

8.  Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK.

Authors:  J Gribbin; R B Hubbard; I Le Jeune; C J P Smith; J West; L J Tata
Journal:  Thorax       Date:  2006-07-14       Impact factor: 9.139

9.  Isolation and characterization of murine multipotent lung stem cells.

Authors:  Ahmed E Hegab; Hiroshi Kubo; Naoya Fujino; Takaya Suzuki; Mei He; Hidemasa Kato; Mutsuo Yamaya
Journal:  Stem Cells Dev       Date:  2010-04       Impact factor: 3.272

10.  Mesenchymal stem cells produce Wnt isoforms and TGF-beta1 that mediate proliferation and procollagen expression by lung fibroblasts.

Authors:  Keith D Salazar; Susan M Lankford; Arnold R Brody
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-09-04       Impact factor: 5.464

View more
  14 in total

Review 1.  Lung-resident mesenchymal stromal cells are tissue-specific regulators of lung homeostasis.

Authors:  Stefanie Noel Sveiven; Tara M Nordgren
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-05-13       Impact factor: 5.464

2.  Sex-specific phenotypes in the aging mouse heart and consequences for chronic fibrosis.

Authors:  Aude Angelini; Jesus Ortiz-Urbina; JoAnn Trial; Anilkumar K Reddy; Anna Malovannaya; Antrix Jain; Mark L Entman; George E Taffet; Katarzyna A Cieslik
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-06-17       Impact factor: 5.125

3.  Endoplasmic reticulum stress modulates the fate of lung resident mesenchymal stem cell to myofibroblast via C/EBP homologous protein during pulmonary fibrosis.

Authors:  Xiaoyu Yang; Wei Sun; Xiaoyan Jing; Qian Zhang; Hui Huang; Zuojun Xu
Journal:  Stem Cell Res Ther       Date:  2022-06-28       Impact factor: 8.079

Review 4.  Mesenchymal Stem/Stromal Cells in Progressive Fibrogenic Involvement and Anti-Fibrosis Therapeutic Properties.

Authors:  Chenghai Li; Bin Wang
Journal:  Front Cell Dev Biol       Date:  2022-06-01

5.  SENP1 regulates the transformation of lung resident mesenchymal stem cells and is associated with idiopathic pulmonary fibrosis progression.

Authors:  Wei Sun; Xiaoshu Liu; Xiaoyu Yang; Xiaoyan Jing; Chunyan Duan; Ganghao Yang; Chi Wu; Hui Huang; Qun Luo; Shu Xia; Qian Zhang; Yang Yang; Zuojun Xu
Journal:  Cell Commun Signal       Date:  2022-07-14       Impact factor: 7.525

6.  Classes of Drugs that Mitigate Radiation Syndromes.

Authors:  Ewa D Micewicz; Robert D Damoiseaux; Gang Deng; Adrian Gomez; Keisuke S Iwamoto; Michael E Jung; Christine Nguyen; Andrew J Norris; Josephine A Ratikan; Piotr Ruchala; James W Sayre; Dörthe Schaue; Julian P Whitelegge; William H McBride
Journal:  Front Pharmacol       Date:  2021-05-18       Impact factor: 5.810

Review 7.  Old Friends with Unexploited Perspectives: Current Advances in Mesenchymal Stem Cell-Based Therapies in Asthma.

Authors:  Marcin Moniuszko; Andrzej Eljaszewicz; Marlena Tynecka
Journal:  Stem Cell Rev Rep       Date:  2021-03-01       Impact factor: 6.692

Review 8.  The Hedgehog Signaling Pathway in Idiopathic Pulmonary Fibrosis: Resurrection Time.

Authors:  Wiwin Is Effendi; Tatsuya Nagano
Journal:  Int J Mol Sci       Date:  2021-12-24       Impact factor: 5.923

Review 9.  Dissecting the Role of Mesenchymal Stem Cells in Idiopathic Pulmonary Fibrosis: Cause or Solution.

Authors:  Anna Valeria Samarelli; Roberto Tonelli; Irene Heijink; Aina Martin Medina; Alessandro Marchioni; Giulia Bruzzi; Ivana Castaniere; Dario Andrisani; Filippo Gozzi; Linda Manicardi; Antonio Moretti; Stefania Cerri; Riccardo Fantini; Luca Tabbì; Chiara Nani; Ilenia Mastrolia; Daniel J Weiss; Massimo Dominici; Enrico Clini
Journal:  Front Pharmacol       Date:  2021-07-05       Impact factor: 5.810

10.  Sonic hedgehog signalling as a potential endobronchial biomarker in COPD.

Authors:  Julien Ancel; Randa Belgacemi; Jeanne-Marie Perotin; Zania Diabasana; Sandra Dury; Maxime Dewolf; Arnaud Bonnomet; Nathalie Lalun; Philippe Birembaut; Myriam Polette; Gaëtan Deslée; Valérian Dormoy
Journal:  Respir Res       Date:  2020-08-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.